{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:13:46Z","timestamp":1790712826015,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T00:00:00Z","timestamp":1411171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11102-014-0600-y","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T13:22:48Z","timestamp":1411132968000},"page":"487-493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Perioperative thromboprophylaxis in Cushing\u2019s disease: What we did and what we are doing?"],"prefix":"10.1007","volume":"18","author":[{"given":"Mattia","family":"Barbot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Daidone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Zilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Albiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Mazzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Chiara","family":"Frigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Scanarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Denaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Casonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,20]]},"reference":[{"key":"600_CR1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","volume":"40","author":"J Etxabe","year":"1994","unstructured":"Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479\u2013484","journal-title":"Clin Endocrinol (Oxf)"},{"key":"600_CR2","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u00f3 E, J\u00f8rgensen JO, Cannegieter SC, Ehrenstein V, Vandenbroucke JP, Pereira AM, S\u00f8rensen HT (2013) Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study. J Clin Endocrinol Metab 98:2277\u20132284","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-13-0569","volume":"169","author":"G Ntali","year":"2013","unstructured":"Ntali G, Asimakopoulou A, Siamatras T, Komninos J, Vassiliadi D, Tzanela M, Tsagarakis S, Grossman AB, Wass JA, Karavitaki N (2013) Mortality in Cushing\u2019s syndrome: systematic analysis of a large series with prolonged follow-up. Eur J Endocrinol 169:715\u2013723","journal-title":"Eur J Endocrinol"},{"key":"600_CR4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-13-0320","volume":"169","author":"M Yaneva","year":"2013","unstructured":"Yaneva M, Kalinov K, Zacharieva S (2013) Mortality in Cushing\u2019s syndrome: data from 386 patients from a single tertiary referral center. Eur J Endocrinol 169:621\u2013627","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"600_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000314349","volume":"92","author":"L Trementino","year":"2010","unstructured":"Trementino L, Arnaldi G, Appolloni G, Daidone V, Scaroni C, Casonato A, Boscaro M (2010) Coagulopathy in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl 1):55\u201359","journal-title":"Neuroendocrinology"},{"key":"600_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000323765","volume":"93","author":"V Daidone","year":"2011","unstructured":"Daidone V, Boscaro M, Pontara E, Cattini MG, Occhi G, Scaroni C, Mantero F, Casonato A (2011) New insight into the hypercoagulability of Cushing\u2019s syndrome. Neuroendocrinology 93:121\u2013125","journal-title":"Neuroendocrinology"},{"key":"600_CR7","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/j.1538-7836.2010.04034.x","volume":"8","author":"B Zaane van","year":"2010","unstructured":"van Zaane B, Nur E, Squizzato A, Gerdes VE, B\u00fcller HR, Dekkers OM, Brandjes DP (2010) Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost 8:2483\u20132493","journal-title":"J Thromb Haemost"},{"key":"600_CR8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03345709","volume":"32","author":"C Erem","year":"2009","unstructured":"Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H (2009) Blood coagulation and fibrinolysis in patients with Cushing\u2019s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest 32:169\u2013174","journal-title":"J Endocrinol Invest"},{"key":"600_CR9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","volume":"36","author":"D Kastelan","year":"2009","unstructured":"Kastelan D, Dusek T, Kraljevic I, Polasek O, Giljevic Z, Solak M, Salek SZ, Jelcic J, Aganovic I, Korsic M (2009) Hypercoagulability in Cushing\u2019s syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine 36:70\u201374","journal-title":"Endocrine"},{"issue":"8943","key":"600_CR10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","volume":"345","author":"T Koster","year":"1995","unstructured":"Koster T, Blann AD, Bri\u00ebt E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345(8943):152\u2013155","journal-title":"Lancet"},{"key":"600_CR11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2141.2007.06907.x","volume":"140","author":"A Casonato","year":"2008","unstructured":"Casonato A, Daidone V, Sartorello F, Albiger N, Romualdi C, Mantero F, Pagnan A, Scaroni C (2008) Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome. Br J Haematol 140:230\u2013235","journal-title":"Br J Haematol"},{"issue":"7","key":"600_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","volume":"343","author":"PA Kyrle","year":"2000","unstructured":"Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 343(7):457\u2013462","journal-title":"N Engl J Med"},{"key":"600_CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF03401535","volume":"11","author":"P Miljic","year":"2012","unstructured":"Miljic P, Miljic D, Cain JW, Korbonits M, Popovic V (2012) Pathogenesis of vascular complications in Cushing\u2019s syndrome. Hormones (Athens) 11:21\u201330","journal-title":"Hormones (Athens)"},{"key":"600_CR14","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","volume":"96","author":"DJ Stuijver","year":"2011","unstructured":"Stuijver DJ, van Zaane B, Feelders RA, Debeij J, Cannegieter SC, Hermus AR, van den Berg G, Pereira AM, de Herder WW, Wagenmakers MA, Kerstens MN, Zelissen PM, Fliers E, Schaper N, Drent ML, Dekkers OM, Gerdes VE (2011) Incidence of venous thromboembolism in patients with Cushing\u2019s syndrome: a multicenter cohort study. J Clin Endocrinol Metab 96:3525\u20133532","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","volume":"163","author":"L Manetti","year":"2010","unstructured":"Manetti L, Bogazzi F, Giovannetti C, Raffaelli V, Genovesi M, Pellegrini G, Ruocco L, Iannelli A, Martino E (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing\u2019s syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163:783\u2013791","journal-title":"Eur J Endocrinol"},{"key":"600_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11102-012-0398-4","volume":"16","author":"S Koutroumpi","year":"2013","unstructured":"Koutroumpi S, Daidone V, Sartori MT, Cattini MG, Albiger NM, Occhi G, Ferasin S, Frigo A, Mantero F, Casonato A, Scaroni C (2013) Venous thromboembolism in patients with Cushing\u2019s syndrome: need of a careful investigation of the prothrombotic risk profile. Pituitary 16:175\u2013181","journal-title":"Pituitary"},{"key":"600_CR17","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","volume":"94","author":"B Zaane Van","year":"2009","unstructured":"Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, Fliers E, Gerdes VE, B\u00fcller HR, Brandjes DP (2009) Hypercoagulable state in Cushing\u2019s syndrome: a systematic review. J Clin Endocrinol Metab 94:2743\u20132750","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12094","volume":"78","author":"R Pas van der","year":"2013","unstructured":"van der Pas R, Leebeek FW, Hofland LJ, de Herder WW, Feelders RA (2013) Hypercoagulability in Cushing\u2019s syndrome: prevalence, pathogenesis and treatment. Clin Endocrinol (Oxf) 78:481\u2013488","journal-title":"Clin Endocrinol (Oxf)"},{"key":"600_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00001721-199904000-00006","volume":"10","author":"A Casonato","year":"1999","unstructured":"Casonato A, Pontara E, Boscaro M, Sonino N, Sartorello F, Ferasin S, Girolami A (1999) Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing\u2019s syndrome. Blood Coagul Fibrinolysis 10:145\u2013151","journal-title":"Blood Coagul Fibrinolysis"},{"key":"600_CR20","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593\u20135602","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1530\/EJE-11-0535","volume":"165","author":"R Swiatkowska-Stodulska","year":"2011","unstructured":"Swiatkowska-Stodulska R, Kaniuka-Jakubowska S, Wisniewski P, Skibowska-Bielinska A, Sworczak K (2011) The estimation of selected endogenous anticoagulation system parameters in patients with subclinical Cushing\u2019s syndrome. Eur J Endocrinol 165:865\u2013871","journal-title":"Eur J Endocrinol"},{"key":"600_CR22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-013-0467-3","volume":"17","author":"S Koutroumpi","year":"2014","unstructured":"Koutroumpi S, Spiezia L, Albiger N, Barbot M, Bon M, Maggiolo S, Gavasso S, Simioni P, Frigo A, Mantero F, Scaroni C (2014) Thrombin generation in Cushing\u2019s Syndrome: do the conventional clotting indices tell the whole truth? Pituitary 17:68\u201375","journal-title":"Pituitary"},{"key":"600_CR23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00001721-199212000-00013","volume":"3","author":"GM Patrassi","year":"1992","unstructured":"Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A (1992) The fibrinolytic potential in patients with Cushing\u2019s disease: a clue to their hypercoagulable state. Blood Coagul Fibrinolysis 3:789\u2013793","journal-title":"Blood Coagul Fibrinolysis"},{"key":"600_CR24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03343697","volume":"23","author":"LM Fatti","year":"2000","unstructured":"Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM (2000) Markers of activation of coagulation and fibrinolysis in patients with Cushing\u2019s syndrome. J Endocrinol Invest 23:145\u2013150","journal-title":"J Endocrinol Invest"},{"key":"600_CR25","doi-asserted-by":"crossref","unstructured":"Sachdeva A, Dalton M, Amaragiri SV, Lees T (2010) Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 7;(7):CD001484. doi: 10.1002\/14651858","DOI":"10.1002\/14651858"},{"key":"600_CR26","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","volume":"141","author":"MK Gould","year":"2012","unstructured":"Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM, American College of Chest Physicians (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest 141:e227S\u2013e277S","journal-title":"Chest"},{"key":"600_CR27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","volume":"157","author":"PV Jenkins","year":"2012","unstructured":"Jenkins PV, Rawley O, Smith OP, O\u2019Donnell JS (2012) Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol 157:653\u2013663","journal-title":"Br J Haematol"},{"key":"600_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-9560-6-13","volume":"6","author":"P Prandoni","year":"2008","unstructured":"Prandoni P (2008) Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: clinical implications of the recent European guidelines. Thromb J 6:13","journal-title":"Thromb J"},{"key":"600_CR29","first-page":"3662","volume":"87","author":"M Boscaro","year":"2002","unstructured":"Boscaro M, Sonino N, Scarda A, Barzon L, Fallo F, Sartori MT, Patrassi GM, Girolami A (2002) Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing\u2019s syndrome. J Clin Endocrinol Metab 87:3662\u20133666","journal-title":"J Clin Endocrinol Metab"},{"key":"600_CR30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1210\/jc.2011-2753","volume":"97","author":"R Pas van der","year":"2012","unstructured":"van der Pas R, de Bruin C, Leebeek FW, de Maat MP, Rijken DC, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, de Jong FH, van der Lely AJ, de Herder WW, Lamberts SW, Hofland LJ, Feelders RA (2012) The hypercoagulable state in Cushing\u2019s disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab 97:1303\u20131310","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-014-0600-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0600-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T05:25:12Z","timestamp":1565846712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-014-0600-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,20]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1007\/s11102-014-0600-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,20]]}}}